Eli Lilly and Company Stock: A Comprehensive Guide
Overview
Eli Lilly and Company (LLY) is a global leader in the pharmaceutical industry. The company has a rich history of innovation, and its products are used by millions of people around the world. LLY is a publicly traded company, and its stock is listed on the New York Stock Exchange.
Key Facts About Eli Lilly and Company
- Headquarters: Indianapolis, Indiana
- Founded: 1876
- Employees: Over 33,000
- Products: Pharmaceuticals, medical devices, and animal health products
- Revenue: Over $28 billion (2021)
Stock Performance
LLY stock has performed well in recent years. The stock has outperformed the S&P 500 Index, and it has generated strong returns for investors.
Key Metrics
- 5-year return: Over 100%
- 10-year return: Over 200%
- Dividend yield: 1.2%
Risks and Opportunities
Like all stocks, LLY stock carries some risks. However, there are also many opportunities for investors.
Risks
- Competition from other pharmaceutical companies
- Regulatory changes
- Clinical trial failures
Opportunities
- Strong pipeline of new products
- Growing demand for pharmaceuticals
- Expanding presence in emerging markets
Conclusion
Eli Lilly and Company is a strong company with a bright future. The company's stock is a good investment for investors who are looking for long-term growth.
Comments